SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: squetch who wrote (13849)1/29/1998 9:09:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
stan, I hope that ABC reads the NY Times. Targretin was extensively discussed in that article (it's linked to the diabetes page at home.att.net ) and it's also been getting good press in Business Week and FT, so the public (and news correspondents?) should be more aware.



To: squetch who wrote (13849)1/29/1998 10:18:00 AM
From: tonyt  Read Replies (1) | Respond to of 32384
 
> I understand that ABC's "Nightline" will feature the advent of new therapies for
> diabetes and is scheduled to be aired this evening.

Thanks.
This could explain the interest in AMLN recently (up 25% in two days).
-- No (or negative) effect on LGND -- Down 1/2 at $11 1/4.

--Tony



To: squetch who wrote (13849)1/29/1998 7:34:00 PM
From: D.Lu  Read Replies (1) | Respond to of 32384
 
ABC Evening News had a short blurb on the use of pancreatic cell implants for treating diabetes, and the remarkable success that procedure has shown. Heard no mention of a company, though the coverage came from Los Angeles. The audio failed on an interview with a Chinese-looking scientist. Jennings quipped afterward something like "you can bet that this treatment is years away from being ready."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News